183 related articles for article (PubMed ID: 24916650)
1. Identifying genetic risk variants for coronary heart disease in familial hypercholesterolemia: an extreme genetics approach.
Versmissen J; Oosterveer DM; Yazdanpanah M; Dehghan A; Hólm H; Erdman J; Aulchenko YS; Thorleifsson G; Schunkert H; Huijgen R; Vongpromek R; Uitterlinden AG; Defesche JC; van Duijn CM; Mulder M; Dadd T; Karlsson HD; Ordovas J; Kindt I; Jarman A; Hofman A; van Vark-van der Zee L; Blommesteijn-Touw AC; Kwekkeboom J; Liem AH; van der Ouderaa FJ; Calandra S; Bertolini S; Averna M; Langslet G; Ose L; Ros E; Almagro F; de Leeuw PW; Civeira F; Masana L; Pintó X; Simoons ML; Schinkel AF; Green MR; Zwinderman AH; Johnson KJ; Schaefer A; Neil A; Witteman JC; Humphries SE; Kastelein JJ; Sijbrands EJ
Eur J Hum Genet; 2015 Mar; 23(3):381-7. PubMed ID: 24916650
[TBL] [Abstract][Full Text] [Related]
2. Familial hypercholesterolemia in the Finnish north Karelia. A molecular, clinical, and genealogical study.
Vuorio AF; Turtola H; Piilahti KM; Repo P; Kanninen T; Kontula K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3127-38. PubMed ID: 9409302
[TBL] [Abstract][Full Text] [Related]
3. Premature coronary heart disease and autosomal dominant hypercholesterolemia: Increased risk in women with LDLR mutations.
Ahmad Z; Li X; Wosik J; Mani P; Petr J; McLeod G; Murad S; Song L; Adams-Huet B; Garg A
J Clin Lipidol; 2016; 10(1):101-8.e1-3. PubMed ID: 26892126
[TBL] [Abstract][Full Text] [Related]
4. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
5. Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease.
Al-Allaf FA; Athar M; Abduljaleel Z; Taher MM; Khan W; Ba-Hammam FA; Abalkhail H; Alashwal A
Gene; 2015 Jul; 565(1):76-84. PubMed ID: 25839937
[TBL] [Abstract][Full Text] [Related]
6. Impact of low-density lipoprotein receptor mutational class on carotid atherosclerosis in patients with familial hypercholesterolemia.
Junyent M; Gilabert R; Jarauta E; Núñez I; Cofán M; Civeira F; Pocoví M; Mallén M; Zambón D; Almagro F; Vega J; Tejedor D; Ros E
Atherosclerosis; 2010 Feb; 208(2):437-41. PubMed ID: 19717150
[TBL] [Abstract][Full Text] [Related]
7. Genetic diagnosis of familial hypercholesterolemia is associated with a premature and high coronary heart disease risk.
Séguro F; Rabès JP; Taraszkiewicz D; Ruidavets JB; Bongard V; Ferrières J
Clin Cardiol; 2018 Mar; 41(3):385-391. PubMed ID: 29574850
[TBL] [Abstract][Full Text] [Related]
8. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
[TBL] [Abstract][Full Text] [Related]
9. P1A1/A2 polymorphism of platelet glycoprotein IIIa and risk of acute coronary syndromes in heterozygous familial hypercholesterolemia.
Cenarro A; Casao E; Civeira F; Jensen HK; Faergeman O; Pocoví M
Atherosclerosis; 1999 Mar; 143(1):99-104. PubMed ID: 10208484
[TBL] [Abstract][Full Text] [Related]
10. Effects of familial hypercholesterolemia-associated genes on the phenotype of premature myocardial infarction.
Lee C; Cui Y; Song J; Li S; Zhang F; Wu M; Li L; Hu D; Chen H
Lipids Health Dis; 2019 Apr; 18(1):95. PubMed ID: 30971288
[TBL] [Abstract][Full Text] [Related]
11. A common variant in the ABCA1 gene is associated with a lower risk for premature coronary heart disease in familial hypercholesterolaemia.
Cenarro A; Artieda M; Castillo S; Mozas P; Reyes G; Tejedor D; Alonso R; Mata P; Pocoví M; Civeira F;
J Med Genet; 2003 Mar; 40(3):163-8. PubMed ID: 12624133
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of genetic polymorphisms and conventional risk factors to predict coronary heart disease in patients with familial hypercholesterolemia.
van der Net JB; Janssens AC; Defesche JC; Kastelein JJ; Sijbrands EJ; Steyerberg EW
Am J Cardiol; 2009 Feb; 103(3):375-80. PubMed ID: 19166692
[TBL] [Abstract][Full Text] [Related]
13. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.
Miserez AR; Martin FJ; Spirk D
Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060
[TBL] [Abstract][Full Text] [Related]
14. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.
Grenkowitz T; Kassner U; Wühle-Demuth M; Salewsky B; Rosada A; Zemojtel T; Hopfenmüller W; Isermann B; Borucki K; Heigl F; Laufs U; Wagner S; Kleber ME; Binner P; März W; Steinhagen-Thiessen E; Demuth I
Atherosclerosis; 2016 Oct; 253():88-93. PubMed ID: 27596133
[TBL] [Abstract][Full Text] [Related]
15. Low-density lipoprotein receptor mutations generate synthetic genome-wide associations.
Oosterveer DM; Versmissen J; Defesche JC; Sivapalaratnam S; Yazdanpanah M; Mulder M; van der Zee L; Uitterlinden AG; van Duijn CM; Hofman A; Kastelein JJ; Aulchenko YS; Sijbrands EJ
Eur J Hum Genet; 2013 May; 21(5):563-6. PubMed ID: 22968135
[TBL] [Abstract][Full Text] [Related]
16. The molecular basis of familial hypercholesterolemia in the Czech Republic: spectrum of LDLR mutations and genotype-phenotype correlations.
Tichý L; Freiberger T; Zapletalová P; Soška V; Ravčuková B; Fajkusová L
Atherosclerosis; 2012 Aug; 223(2):401-8. PubMed ID: 22698793
[TBL] [Abstract][Full Text] [Related]
17. Impact of LDLR and PCSK9 pathogenic variants in Japanese heterozygous familial hypercholesterolemia patients.
Hori M; Ohta N; Takahashi A; Masuda H; Isoda R; Yamamoto S; Son C; Ogura M; Hosoda K; Miyamoto Y; Harada-Shiba M
Atherosclerosis; 2019 Oct; 289():101-108. PubMed ID: 31491741
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms in LDLR, APOB, PCSK9 and other lipid related genes associated with familial hypercholesterolemia in Malaysia.
Lye SH; Chahil JK; Bagali P; Alex L; Vadivelu J; Ahmad WA; Chan SP; Thong MK; Zain SM; Mohamed R
PLoS One; 2013; 8(4):e60729. PubMed ID: 23593297
[TBL] [Abstract][Full Text] [Related]
19. Relative contribution of low-density lipoprotein receptor and lipoprotein lipase gene mutations to angiographically assessed coronary artery disease among French Canadians.
Gaudet D; Vohl MC; Julien P; Tremblay G; Perron P; Gagné C; Bergeron J; Moorjani S; Després JP
Am J Cardiol; 1998 Aug; 82(3):299-305. PubMed ID: 9708657
[TBL] [Abstract][Full Text] [Related]
20. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P;
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
